Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-25-000041·Forte Biosciences, Inc.
Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock · CUSIP: 34962G208
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 690,743 · Class: 10.0%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 690,743 · Class: 10.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000041
- Form type
- SCHEDULE 13G
- Filer
- Forte Biosciences, Inc.
- CIK
- CIK 1419041
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership